Quest Diagnostics, Inc. DGX

NYS: DGX | ISIN: US74834L1008 2/02/2026

185,00 USD (-1,09%)

(-1,09%) 2/02/2026

Grafiek Quest Diagnostics, Inc.

Grafiek Quest Diagnostics, Inc.

1 dag1d -1,09%
1 week1w 1,24%
1 maand1m 6,63%
3 maanden3m 3,92%
6 maanden6m 7,28%
1 jaar1j 13,25%
5 jaar5j 51,65%

dinsdag 10 februari 2026, 13:00

Kwartaalcijfers (4de kwartaal)

Quest Diagnostics, Inc. in het nieuws

Toon enkel gratis nieuws

2 februari 2026 · Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease · Persbericht

21 januari 2026 · Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year · Persbericht

15 januari 2026 · Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect · Persbericht

8 januari 2026 · Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026 · Persbericht

6 januari 2026 · Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium · Persbericht

5 januari 2026 · Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan · Persbericht

19 december 2025 · Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

11 november 2025 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

3 november 2025 · Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference · Persbericht

27 oktober 2025 · New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis · Persbericht

Profiel Quest Diagnostics, Inc.

Diensten aan de gezondheidssector

Gezondheidszorg

Tandheelkundige laboratoria

Website: www.questdiagnostics.com

Hoofdzetel: Secaucus, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe